28 Million Americans are currently fighting cancer. However, with ongoing cancer research and new combination treatments, patients have a better understanding of what to expect from various types of cancer.
Immunotherapy has been slower to demonstrate progress in gynecologic cancers than in several other solid tumors, experts say. “We have not increased the number of patients that we have cured of ovarian cancer in the past 20 or 30 years,” states Dmitriy Zamarin, MD, PhD. Success with these agents may rely on combination approaches, which has shown improvement in responses with other cancer types, such as melanoma.
This article orginally posted on onclive.com.
